Widex-Developed Artificial Intelligence Promises to Revolutionize Hearing Aids

Widex is the first hearing aid company to use AI to optimize hearing aid performance in real-time.

Widex notes having transformed the performance of a broad spectrum of consumer and industrial products, artificial intelligence (AI) is now set to revolutionize the quality of a product that the U.S. National Institutes of Health says half of the consumers aged 75 and over desperately need: hearing aids.

Bringing opportunity to fruition, Widex is the first hearing aid manufacturer to utilize real-time AI to create a better, more natural and personalized sound experience for hearing aid users. “By applying artificial intelligence, a hearing solution learns how users prefer various listening environments and gives them greater control over their hearing experience,” Widex Head of Audiology Lise Henningsen said. “By being the first to embrace AI, Widex benefits from years of continuous machine learning and hearing aid optimization that other hearing aid manufacturers have not yet developed. It is a key reason Widex is able to deliver its revolutionary natural sound.”

Powered by AI, Widex SoundSense Learn processes inputs from connected hearing aids throughout the world and shares anonymized data with a cloud-based AI system. The system then continuously learns how to further optimize hearing aid settings in different situations for specific wearers.

Widex SoundSense Learn presents users with A-B comparisons to begin understanding how a person wearing compatible Widex hearing aids prefers sound in an environment. SoundSense Learn manages three acoustic parameters — low, mid, and high frequencies — which can each be set to 13 different levels, resulting in more than 2,000 possible settings.

To A-B test each setting would require more than 2 million tests, but by using the power of machine-learning algorithms, Widex SoundSense Learn requires only about a dozen comparisons to calculate the optimal settings for the individual person. The SoundSense Learn algorithms also track the user’s individual adjustments and draw from other user settings stored in the cloud to more precisely tailor the hearing aids to one’s surroundings.

When applied, the settings create a personalized hearing experience based on context, content, and intent. Users can store the settings as programs in their smartphones and activate them throughout the day, such as when they’re at work, at the supermarket, or in their kitchen. Anonymized, the programs can also be stored in a secure, cloud-based system and help enhance the hearing experience of other users.

“Our studies show that hearing aid users have a significant preference for the personalized settings achieved through artificial intelligence and machine learning, and that 80 percent would recommend the function to others,” Henningsen added.

AI-equipped hearing aids such as the WIDEX MOMENT enhance our digital lives. “With AI, they are more like new lifestyle ‘hearables,’ which are key contributors to ubiquitous computing, just as virtual assistants and smart watches are,” Henningsen concluded.

SourceWidex
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version